Chemoinformaics analysis of Ingenol 2,4,6,8,10-tetradecapentaenoate
Molecular Weight | 548.72 | nRot | 9 |
Heavy Atom Molecular Weight | 504.368 | nRig | 25 |
Exact Molecular Weight | 548.314 | nRing | 4 |
Solubility: LogS | -3.677 | nHRing | 0 |
Solubility: LogP | 3.406 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 84 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 40 | No. of Aromatic Carbocycles | 0 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 34 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
nHA | 6 | APOL | 90.9309 |
nHD | 3 | BPOL | 47.6131 |
QED | 0.163 |
Synth | 6.664 |
Natural Product Likeliness | 2.16 |
NR-PPAR-gamma | 0.02 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.654 |
Pgp-sub | 0 |
HIA | 0.032 |
CACO-2 | -5.072 |
MDCK | 0.0000149 |
BBB | 0.302 |
PPB | 0.830529 |
VDSS | 0.862 |
FU | 0.0487504 |
CYP1A2-inh | 0.154 |
CYP1A2-sub | 0.111 |
CYP2c19-inh | 0.743 |
CYP2c19-sub | 0.851 |
CYP2c9-inh | 0.876 |
CYP2c9-sub | 0.998 |
CYP2d6-inh | 0.956 |
CYP2d6-sub | 0.925 |
CYP3a4-inh | 0.95 |
CYP3a4-sub | 0.469 |
CL | 1.166 |
T12 | 0.007 |
hERG | 0.351 |
Ames | 0.053 |
ROA | 0.943 |
SkinSen | 0.847 |
Carcinogencity | 0.092 |
EI | 0.01 |
Respiratory | 0.918 |
NR-Aromatase | 0.745 |
Antiviral | Yes |
Prediction | 0.811762 |